Completing treatment for latent tuberculosis: Patient background matters

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 5, 2013, Pages 597-602

  Kan, Boris ^a   Kalin, M ^a   Bruchfeld, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adherence; Contacts; Immigrant; Somalia

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC GROUP; EUROPEAN; FEMALE; HELP SEEKING BEHAVIOR; HUMAN; INSTITUTIONALIZATION; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SOMALIA; SWEDEN; TREATMENT COMPLETION; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING; TREND STUDY; TUBERCULIN TEST; UNIVERSITY HOSPITAL;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; ANTITUBERCULAR AGENTS; CULTURAL CHARACTERISTICS; EMIGRANTS AND IMMIGRANTS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LATENT TUBERCULOSIS; LOGISTIC MODELS; MALE; MEDICATION ADHERENCE; ODDS RATIO; REFUGEES; RISK FACTORS; SOMALIA; SWEDEN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84876856045     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0692     Document Type: Article

References (34)

1. Blumberg H M, Migliori G B, Ponomarenko O, Heldal E. Tuberculosis on the move. Lancet 2010; 375: 2127-2129.
2. Borgdorff M W, van den Hof S, Kremer K, et al. Progress towards tuberculosis elimination: secular trend, immigration and transmission. Eur Respir J 2010; 36: 339-347.
3. Horsburgh C R Jr, Rubin E J. Clinical practice. Latent tuberculosis infection in the United States. N Engl J Med 2011; 364: 1441-1448.
4. Leung C C, Rieder H L, Lange C, Yew W W. Treatment of latent infection with Mycobacterium tuberculosis: update 2010. Eur Respir J 2011; 37: 690-711.
5. Hirsch-Moverman Y, Daftary A, Franks J, Colson P W. Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int J Tuberc Lung Dis 2008; 12: 1235-1254.
6. Sumartojo E. When tuberculosis treatment fails. A social behavioral account of patient adherence. Am Rev Respir Dis 1993; 147: 1311-1320. (Pubitemid 23149899)
7. Horsburgh C R Jr, Goldberg S, Bethel J, et al. Latent TB infection treatment acceptance and completion in the United States and Canada. Chest 2010; 137: 401-409.
8. Hill L, Blumberg E, Sipan C, et al. Multi-level barriers to LTBI treatment: a research note. J Immigr Minor Health 2010; 12: 544-550.
9. Hirsch-Moverman Y, Bethel J, Colson P W, Franks J, El-Sadr W. Predictors of latent tuberculosis infection treatment completion in the United States: an inner city experience. Int J Tuberc Lung Dis 2010; 14: 1104-1111.
10. Swedish Institute for Infectious Disease Control. Statistics for tuberculosis. Stockholm, Sweden: Swedish Institute for Infectious Disease Control, 2011. http://smittskyddsinstitutet.se/statistik/tuberkulos/?t= com&p=18211#statistics-nav Accessed January 2013.
11. Swedish Migration Board. Statistics: applications for asylum received 1984-2011. Stockholm, Sweden: Swedish Migration Board. http://www. migrationsverket.se/download/18.78fcf371269cd4cda980004204/tabs2.pdf Accessed January 2013.
12. Kan B, Berggren I, Ghebremichael S, et al. Extensive transmission of an isoniazid-resistant strain of Mycobacterium tuberculosis in Sweden. Int J Tuberc Lung Dis 2008; 12: 199-204. (Pubitemid 351212413)
13. Shetty N, Shemko M, Abbas A. Knowledge, attitudes and practices regarding tuberculosis among immigrants of Somalian ethnic origin in London: a cross-sectional study. Commun Dis Public Health 2004; 7: 77-82.
14. Centers for Disease Control and Prevention. Promoting cultural sensitivity: a practical guide for tuberculosis programs that provide services to persons from Somalia. Atlanta, GA, USA: US Department of Health and Human Services, 2008.
15. Gerrish K, Naisby A, Ismail M. The meaning and consequences of tuberculosis among Somali people in the United Kingdom. J Adv Nurs 2012; 68: 2654-2663.
16. Morrison T B, Wieland M L, Cha S S, Rahman A S, Chaudhry R. Disparities in preventive health services among Somali immigrants and refugees. J Immigr Minor Health 2012; 14: 968-974.
17. Kulane A, Ahlberg B M, Berggren I. 'It is more than the issue of taking tablets': the interplay between migration policies and TB control in Sweden. Health Policy 2010; 97: 26-31.
18. Colson P W, Franks J, Sondengam R, Hirsch-Moverman Y, El-Sadr W. Tuberculosis knowledge, attitudes and beliefs in foreignborn and US-born patients with latent tuberculosis infection. J Immigr Minor Health 2010; 12: 859-866.
19. Goldberg S V, Wallace J, Jackson J C, Chaulk C P, Nolan C M. Cultural case management of latent tuberculosis infection. Int J Tuberc Lung Dis 2004; 8: 76-82. (Pubitemid 38120709)
20. Coreil J, Lauzardo M, Heurtelou M. Cultural feasibility assessment of tuberculosis prevention among persons of Haitian origin in South Florida. J Immigr Health 2004; 6: 63-69.
21. Shieh F K, Snyder G, Horsburgh C R, Bernardo J, Murphy C, Saukkonen J J. Predicting non-completion of treatment for latent tuberculous infection: a prospective survey. Am J Respir Crit Care Med 2006; 174: 717-721. (Pubitemid 44395341)
22. Ailinger R L, Martyn D, Lasus H, Lima Garcia N. The effect of a cultural intervention on adherence to latent tuberculosis infection therapy in Latino immigrants. Public Health Nurs 2010; 27: 115-120.
23. Farah M G, Meyer H E, Selmer R, Heldal E, Bjune G. Longterm risk of tuberculosis among immigrants in Norway. Int J Epidemiol 2005; 34: 1005-1011. (Pubitemid 41535544)
24. Cain K P, Benoit S R, Winston C A, Mac Kenzie W R. Tuberculosis among foreign-born persons in the United States. JAMA 2008; 300: 405-412. (Pubitemid 352040252)
25. Trajman A, Long R, Zylberberg D, Dion M J, Al-Otaibi B, Menzies D. Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment. Int J Tuberc Lung Dis 2010; 14: 551-559.
26. Li J, Munsiff S S, Tarantino T, Dorsinville M. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City. Int J Infect Dis 2010; 14: e292-297.
27. Matteelli A, Casalini C, Raviglione M C, et al. Supervised preventive therapy for latent tuberculosis infection in illegal immigrants in Italy. Am J Respir Crit Care Med 2000; 162: 1653-1655.
28. Rennie T W, Bothamley G H, Engova D, Bates I P. Patient choice promotes adherence in preventive treatment for latent tuberculosis. Eur Respir J 2007; 30: 728-735. (Pubitemid 351194834)
29. Anibarro L, Casas S, Paz-Esquete J, et al. Treatment completion in latent tuberculosis infection at specialist tuberculosis units in Spain. Int J Tuberc Lung Dis 2010; 14: 701-707.
30. Parsyan A E, Saukkonen J, Barry M A, Sharnprapai S, Horsburgh C R Jr. Predictors of failure to complete treatment for latent tuberculosis infection. J Infect 2007; 54: 262-266. (Pubitemid 46238167)
31. LoBue P A, Moser K S. Use of isoniazid for latent tuberculosis infection in a public health clinic. Am J Respir Crit Care Med 2003; 168: 443-447. (Pubitemid 37046873)
32. Coly A, Morisky D. Predicting completion of treatment among foreign-born adolescents treated for latent tuberculosis infection in Los Angeles. Int J Tuberc Lung Dis 2004; 8: 703-710. (Pubitemid 38747146)
33. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva, Switzerland: WHO, 2003. http://www.who.int/chp/knowledge/ publications/adherence-full- report.pdf Accessed January 2013.
34. van der Oest C, Chenhall R, Hood D, Kelly P. Talking about TB: multicultural diversity and tuberculosis services in Waikato, New Zealand. N Z Med J 2005; 118: U1496.